Lyrus Life Sciences

Bengaluru, India Founded: 2015 • Age: 11 yrs
Research-driven firm specializing in pharmaceutical formulation development and manufacturing services.

About Lyrus Life Sciences

Lyrus Life Sciences is a Healthcare company based in Bengaluru (India) founded in 2015. Research-driven firm specializing in pharmaceutical formulation development and manufacturing services. It operates on a B2B model. Lyrus Life Sciences offers products and services including Formulation Development, Analytical Development, and Pilot and Exhibit Manufacturing. Its focus areas include Pharmaceuticals, Formulation Development, Drug Delivery and Manufacturing. Its legal entity is Lyrus Life Science Pvt. Ltd. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Lyrus Life Sciences is a global specialty pharmaceutical company focused on research and technology for innovative drug delivery solutions. They provide integrated services in formulation development, analytical testing, and manufacturing, supported by a qualified team. Based primarily in Bangalore, India, with additional offices in the UK and USA, they serve clients in chronic and critical therapies across various segments. Their operations emphasize quality, regulatory compliance, and affordability in medicines.

  • Headquarters Bengaluru, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website lyruslife.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Lyrus Life Science Pvt. Ltd.

Products & Services of Lyrus Life Sciences

Lyrus Life Sciences offers a comprehensive portfolio of products and services, including Formulation Development, Analytical Development, and Pilot and Exhibit Manufacturing.

Formulation Development
R&D Service

Offers comprehensive pre-formulation and development for robust drug products.

Analytical Development
Testing Service

Provides cGMP-compliant analytical support for drug development phases.

Pilot and Exhibit Manufacturing
Production Service

Facilitates scale-up and manufacturing of pharmaceutical products globally.

Apps and channels of Lyrus Life Sciences

its YouTube channel Lyrus has 81 subscribers and 4 videos.

Lyrus
YouTube 81 subscribers 4 videos Science & Technology
Open channel

Videos from Lyrus Life Sciences

The most watched videos on Lyrus Life Sciences's YouTube channel, Lyrus (81 subscribers). Click a video to play it here.

Glaucoma can lead to blindness.
11.5K views
Lyrus Corporate AV
803 views
Lyrus short corporate AV
265 views
Glaucoma: Detect Early, Prevent Irreversible Blindness
13 views

More on Lyrus.

Board of directors of Lyrus Life Sciences

The boards of the 3 registered companies of Lyrus Life Sciences currently have 6 directors; the longest-serving is Leela Kanwar, appointed in 2015. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Leela Kanwar
DIN 07110887
Director16 Jun 201511 yrs 5 moLyrus Life Sciences Private Limited
Kiran Divakaran
DIN 06438548
Partner04 Oct 20179 yrs 1 moPro-Trust Llp
Piyush Sharma
DIN 07003294
Designated Partner04 Oct 20179 yrs 1 moPro-Trust Llp
Hemanth Kumar Bothra
DIN 00033274
Designated Partner04 Oct 20179 yrs 1 moPro-Trust Llp, Lyrus Life Sciences Private Limited
Dasari Ramesh
DIN 02421103
Designated Partner23 May 20197 yrs 5 moIzumi Beverages Llp
Vandana Bothra
DIN 11407257
Designated Partner04 Dec 202511 moIzumi Beverages Llp

Financials of Lyrus Life Sciences

Figures of Lyrus Life Sciences Private Limited, the primary company behind Lyrus Life Sciences, for FY 2025. Revenue was ₹60.95 Cr (-22% year on year). Net loss was -₹11.73 Cr (-19% margin). EBITDA was ₹5.21 Cr (9% margin). Revenue has grown at a compounded annual rate of -13% over three years and +2% over five years.

  • ₹60.95 CrRevenue · FY 2025 · -22% YoY
  • -₹11.73 CrNet loss · -19% margin
  • ₹5.21 CrEBITDA · 9% margin
  • ₹96.23 CrPaid-up capital
  • 104Employees (provident fund records)
  • -13%Revenue CAGR, 3 years
  • +2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Lyrus Life Sciences Private Limited are on its company page.

Premium access

Detailed financial statements for Lyrus Life Sciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Lyrus Life Sciences

Lyrus Life Sciences has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Lyrus Life Sciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Lyrus Life Sciences

The website of Lyrus Life Sciences (lyruslife.com) receives about 1.3K visits a month.

  • Monthly visits
    1.3K

    ▼ 1.1% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Lyrus Life Sciences (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lyrus Life Sciences

Premium access

Complete news archive for Lyrus Life Sciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lyrus Life Sciences

Lyrus Life Sciences was founded in 2015.

Lyrus Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Lyrus Life Sciences is a global specialty pharmaceutical company focused on research and technology for innovative drug delivery solutions. They provide integrated services in formulation development, analytical testing, and manufacturing, supported by a qualified team. Based primarily in Bangalore, India, with additional offices in the UK and USA, they serve clients in chronic and critical therapies across various segments. Their operations emphasize quality, regulatory compliance, and affordability in medicines.

Lyrus Life Sciences's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Lyrus Life Sciences offers Formulation Development, Analytical Development, and Pilot and Exhibit Manufacturing.

Lyrus Life Sciences is associated with 3 legal entities: Pro-Trust Llp, Izumi Beverages Llp, Lyrus Life Sciences Private Limited.

The legal entities of Lyrus Life Sciences currently have 6 directors, including Kiran Divakaran, Piyush Sharma, Hemanth Kumar Bothra and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available